Immunocore Holdings plc (IMCR)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 150M 300M 450M Q3 '24: 296.3M Q4 '24: 310.2M Q1 '25: 333.6M Q2 '25: 356.1M Q3 '25: 379.6M Q4 '25: 400M Q1 '26: 412.8M Q2 '26: 430.8M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit TTM

0 150M 300M 450M Q3 '24: 293.7M Q4 '24: 307.5M Q1 '25: 330.3M Q2 '25: 353.5M Q3 '25: 376.9M Q4 '25: 394.9M Q1 '26: 408.1M Q2 '26: 426M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income TTM

-75M -50M -25M 0 25M 50M 75M Q3 '24: -68.1M Q4 '24: -70.5M Q1 '25: -47.6M Q2 '25: -46.4M Q3 '25: -45.1M Q4 '25: -45.4M Q1 '26: -34.5M Q2 '26: -22.6M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income TTM

-60M -40M -20M 0 20M 40M 60M Q3 '24: -47M Q4 '24: -51.1M Q1 '25: -21.6M Q2 '25: -20.3M Q3 '25: -29.2M Q4 '25: -35.5M Q1 '26: -27.6M Q2 '26: -18.1M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue TTM

0 2M 4M 6M Q3 '24: 2.6M Q4 '24: 2.7M Q1 '25: 3.3M Q2 '25: 2.6M Q3 '25: 2.7M Q4 '25: 5.1M Q1 '26: 4.7M Q2 '26: 4.7M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow TTM

0 15M 30M 45M Q4 '24: 26.1M Q1 '25: 31.1M Q2 '25: 33.6M Q3 '25: 8M Q4 '24 Q1 '25 Q2 '25 Q3 '25

Free Cash Flow TTM

0 10M 20M 30M Q4 '24: 20.9M Q1 '25: 26M Q2 '25: 28.5M Q3 '25: 2.9M Q4 '24 Q1 '25 Q2 '25 Q3 '25

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q1 '24: 49.9M Q2 '24: 50M Q3 '24: 52.8M Q1 '25: 51.9M Q2 '25: 50.3M Q3 '25: 50.4M Q1 '26: 52.9M Q2 '26: 51M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-1.05 -0.70 -0.35 0.00 0.35 0.70 1.05 Q3 '24: -0.95 Q4 '24: -1.02 Q1 '25: -0.43 Q2 '25: -0.40 Q3 '25: -0.57 Q4 '25: -0.70 Q1 '26: -0.55 Q2 '26: -0.37 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.